[Federal Register: November 16, 2007 (Volume 72, Number 221)]
[Notices]
[Page 64674-64675]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16no07-130]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on June 13, 2007, Archimica,
Inc., 2460 W. Bennett Street, Springfield, Missouri 65807-1229, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
[[Page 64675]]
the basic classes of controlled substances listed in schedule II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methylphenidate (1724)..................... II
Phenylacetone (8501)....................... II
Methadone Intermediate (9254).............. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for research purposes, and sale to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 15, 2008.
Dated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-22519 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P